{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:49:02Z","timestamp":1793836142370,"version":"4.6.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"am","delay-in-days":256,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21AG077310"],"award-info":[{"award-number":["R21AG077310"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","annalsofvascularsurgery.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.avsg.2024.06.041","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T01:59:14Z","timestamp":1722045554000},"page":"273-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The Use of Clot Strength as a Predictor of Thrombosis in Peripheral Artery Disease"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0965-7258","authenticated-orcid":false,"given":"Sasha","family":"Suarez Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniket","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Cieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Ghandour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leela","family":"Morena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanah","family":"Hagos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Grobman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellie","family":"Machlus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahita","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2024.06.041_bib1","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/01.CIR.71.3.510","article-title":"The prevalence of peripheral arterial disease in a defined population","volume":"71","author":"Criqui","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.06.041_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2147\/CIA.S2412","article-title":"Peripheral arterial disease in the elderly","volume":"2","author":"Aronow","year":"2007","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.avsg.2024.06.041_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/2050312120929239","article-title":"Lower extremity revascularization via endovascular and surgical approaches: a systematic review with emphasis on combined inflow and outflow revascularization","volume":"8","author":"Mustapha","year":"2020","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.avsg.2024.06.041_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.avsg.2021.02.025","article-title":"Incidence of major atherothrombotic vascular events among patients with peripheral artery disease after revascularization","volume":"75","author":"Desai","year":"2021","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2024.06.041_bib5","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/jth.15673","article-title":"Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: dual anticoagulant\/antiplatelet regimen vs antiplatelet therapy alone","volume":"20","author":"Berkowitz","year":"2022","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.avsg.2024.06.041_bib6","first-page":"417","article-title":"Lower extremity amputation in peripheral artery disease: improving patient outcomes","volume":"16","author":"Swaminathan","year":"2014","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.avsg.2024.06.041_bib7","first-page":"e686","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.06.041_bib8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jvs.2022.08.015","article-title":"Variability of antiplatelet response in patients with peripheral artery disease","volume":"77","author":"Majumdar","year":"2023","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.06.041_bib9","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.2174\/1381612825666190101111123","article-title":"Clopidogrel resistance in lower extremity arterial endovascular interventions","volume":"24","author":"Markel","year":"2018","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.avsg.2024.06.041_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.avsg.2024.06.041_bib11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/ATVBAHA.119.312142","article-title":"Evidence-based medical management of peripheral artery disease","volume":"40","author":"Bevan","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.avsg.2024.06.041_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.avsg.2023.08.004","article-title":"Impact of factor Xa inhibition on coagulation, platelet reactivity, and thrombosis in patients with peripheral artery disease","volume":"97","author":"Hall","year":"2023","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2024.06.041_bib13","first-page":"259","article-title":"Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls","volume":"11","author":"Winter","year":"2015","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"10.1016\/j.avsg.2024.06.041_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3389\/fped.2019.00509","article-title":"TEG platelet mapping and impedance aggregometry to predict platelet transfusion during cardiopulmonary bypass in pediatric patients","volume":"7","author":"Barker","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.avsg.2024.06.041_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.tmrv.2021.08.002","article-title":"Viscoelastic testing in traumatic brain injury: key research insights","volume":"35","author":"Anderson","year":"2021","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.avsg.2024.06.041_bib16","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ejvs.2019.06.017","volume":"58","author":"Venermo","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2024.06.041_bib17","article-title":"Intervention to optimize follow-up after lower extremity revascularization","volume":"1","author":"Kim","year":"2023","journal-title":"JVS Vasc Insights"},{"key":"10.1016\/j.avsg.2024.06.041_bib19","first-page":"E67","article-title":"The current US prevalence of peripheral arterial disease","volume":"20","author":"Yost","year":"2023","journal-title":"Vasc Dis Manag"},{"key":"10.1016\/j.avsg.2024.06.041_bib20","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.avsg.2024.06.041_bib22","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1160\/th14-02-0184","article-title":"Clot properties and cardiovascular disease","volume":"112","author":"Bridge","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.avsg.2024.06.041_bib23","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/01.ATV.0000241589.52950.4c","article-title":"Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis","volume":"26","author":"Collet","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.avsg.2024.06.041_bib24","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/01.CIR.0000033221.73082.06","article-title":"Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease","volume":"106","author":"Mills","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.06.041_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071150","article-title":"Fibrin clot structure and platelet aggregation in patients with aspirin treatment failure","volume":"8","author":"Neergaard-Petersen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.avsg.2024.06.041_bib26","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/j.1538-7836.2007.02637.x","article-title":"Altered fibrin clot structure in patients with advanced coronary artery disease: a role of C-reactive protein, lipoprotein(a) and homocysteine","volume":"5","author":"Undas","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.avsg.2024.06.041_bib27","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1016\/j.thromres.2013.07.012","article-title":"Plasma and whole blood clot strength measured by thrombelastography in patients treated with clopidogrel during acute coronary syndromes","volume":"132","author":"Lu","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.avsg.2024.06.041_bib28","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/MBC.0b013e32834bdb32","article-title":"Differences in fibrin fiber diameters in healthy individuals and thromboembolic ischemic stroke patients","volume":"22","author":"Pretorius","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.avsg.2024.06.041_bib29","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/STROKEAHA.108.532812","article-title":"Altered fibrin clot structure\/function in patients with cryptogenic ischemic stroke","volume":"40","author":"Undas","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.avsg.2024.06.041_bib30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.thromres.2009.11.013","article-title":"Fibrin clot properties in acute ischemic stroke: relation to neurological deficit","volume":"125","author":"Undas","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.avsg.2024.06.041_bib31","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1161\/ATVBAHA.111.236786","article-title":"Clot architecture is altered in abdominal aortic aneurysms and correlates with aneurysm size","volume":"31","author":"Scott","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.avsg.2024.06.041_bib32","series-title":"StatPearls [internet]","article-title":"Thromboelastography. [Updated 2023 apr 10]","author":"Shaydakov","year":"2024"},{"key":"10.1016\/j.avsg.2024.06.041_bib33","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s11239-020-02103-w","article-title":"The Impact of platelet\u2013fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease","volume":"50","author":"Bae","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.avsg.2024.06.041_bib34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11936-009-0003-y","article-title":"Selecting optimal antiplatelet therapy based on platelet function monitoring in patients with coronary artery disease","volume":"11","author":"Gurbel","year":"2009","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.avsg.2024.06.041_bib35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.20452\/pamw.390","article-title":"Antiplatelet treatment of cardiovascular disease: a translational research perspective","volume":"118","author":"Gurbel","year":"2008","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.avsg.2024.06.041_bib36","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.jacc.2007.07.051","article-title":"Platelet function monitoring in patients with coronary artery disease","volume":"50","author":"Gurbel","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2024.06.041_bib37","first-page":"B86","article-title":"First evidence of the stepwise relation between on-treatment platelet reactiv- ity to ADP and post-PCI ischemic events: first evidence for a potential therapeutic target for P2Y12 inhibitors","volume":"52","author":"Gurbel","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2024.06.041_bib38","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jacc.2007.12.044","article-title":"Adjusted clopidogrel loading doses according to vasodilator-stimu- lated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospec- tive study","volume":"51","author":"Bonello","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2024.06.041_bib39","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ahj.2010.05.034","article-title":"Adenosine diphosphate\u2013induced platelet-fibrin clot strength: a new thrombelastographic indicator of long-term poststenting ischemic events","volume":"160","author":"Gurbel","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.avsg.2024.06.041_bib40","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027790","article-title":"Predicting arterial thrombotic events following peripheral revascularization using objective viscoelastic data","volume":"12","author":"Majumdar","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2024.06.041_bib41","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCRESAHA.121.318535","article-title":"Epidemiology of peripheral artery disease and polyvascular disease","volume":"128","author":"Aday","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.avsg.2024.06.041_bib42","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1161\/01.CIR.0000074227.53616.CC","article-title":"D-dimer, Inflammatory markers, and lower extremity functioning in patients with and without peripheral","volume":"107","author":"McDermott","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.06.041_bib43","first-page":"3191","article-title":"Arterial disease","volume":"107","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.06.041_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1358863X15617541","article-title":"Changes in D-dimer and inflammatory biomarkers before ischemic events in patients with peripheral artery disease: the BRAVO Study","volume":"21","author":"McDermott","year":"2016","journal-title":"Vasc Med"},{"key":"10.1016\/j.avsg.2024.06.041_bib45","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1053\/euhj.2001.3116","article-title":"D-dimer and platelet aggregability are related to thrombotic events in patients with peripheral arterial occlusive disease","volume":"23","author":"Komarov","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.avsg.2024.06.041_bib46","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1161\/01.CIR.90.6.2679","article-title":"Fibrin formation and degradation in patients with arteriosclerotic disease","volume":"90","author":"Herren","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.06.041_bib47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejvs.2004.11.001","article-title":"Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease","volume":"29","author":"Cassar","year":"2005","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2024.06.041_bib48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/eurheartj\/16.1.38","article-title":"D-dimer and fibrinolysis in patients with various degrees of atherosclerosis","volume":"16","author":"Panchenko","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.avsg.2024.06.041_bib49","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jvs.2007.05.039","article-title":"Platelet activation increases with the severity of peripheral arterial disease: implications for clinical management","volume":"46","author":"Rajagopalan","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.06.041_bib50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/07853890410018943","article-title":"Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers","volume":"37","author":"Tan","year":"2005","journal-title":"Ann Med"},{"key":"10.1016\/j.avsg.2024.06.041_bib51","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.thromres.2014.12.029","article-title":"Normal platelet activation profile in patients with peripheral arterial disease on aspirin","volume":"135","author":"van Geffen","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.avsg.2024.06.041_bib52","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCRESAHA.121.318535","article-title":"Epidemiology of peripheral artery disease and polyvascular disease","volume":"128","author":"Aday","year":"2021","journal-title":"Circ Res"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509624004813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509624004813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T23:32:27Z","timestamp":1732577547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509624004813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":50,"alternative-id":["S0890509624004813"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2024.06.041","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Use of Clot Strength as a Predictor of Thrombosis in Peripheral Artery Disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2024.06.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}